ATLASiShares Global Healthcare ETF (IXJ): outlook, holdings and fees
iShares Global Healthcare ETF (IXJ) is an exchange-traded fund and is managed by iShares. The expense ratio is 0.42% and the yield is 1.42%. The ten largest holdings are 47% of the fund.
Fund data as of Oct 14, 2026 · Price Nov 2, 2026
ATLAS view on IXJ
| Last price | $112.66 (+0.8%) |
|---|---|
| ATLAS chance of a higher price in 1 month | 54% |
| Likely 1-month range (50%) | $109.86 – $116.60 |
| Normal 1-day range (±1σ) | ±1.0% |
| Distribution yield | 1.42% |
ATLAS probabilities use the same calibrated model as every stock page. A fair value is shown for companies, not funds; the holdings below link to the fair value of each company.
IXJ fund facts
| Issuer | iShares |
|---|---|
| Theme | Healthcare |
| Assets under management | $4.4B |
| Expense ratio | 0.42% |
| Number of holdings | 108 |
| Portfolio turnover | 3% |
| Inception | Nov 13, 2001 |
| Exchange | NYSE |
The fund seeks to track the investment results of the S&P Global 1200 Health Care (Sector) Capped IndexTM (the "underlying index"), which measures the performance of companies that S&P Dow Jones Indices LLC (the "index provider" or "SPDJI"), a subsidiary of S&P Global, Inc., deems to be a part of the healthcare sector of the economy and that SPDJI believes are important to global markets. The underlying index is a subset of the S&P Global 1200, which is designed to measure the performance of large-capitalization stocks from major global markets, as determined by SPDJI.
IXJ top holdings
| Holding | Sector | Weight |
|---|---|---|
| Eli Lilly and Company LLY | Healthcare | 10.43% |
| Johnson & Johnson JNJ | Healthcare | 7.22% |
| AbbVie Inc ABBV | Healthcare | 5.27% |
| Merck & Company Inc MRK | Healthcare | 4.51% |
| UnitedHealth Group Incorporated UNH | Healthcare | 4.13% |
| Roche Holding AG ROP | Healthcare | 3.76% |
| Novartis AG NOVN | Healthcare | 3.21% |
| AstraZeneca PLC AZN | Healthcare | 3.15% |
| Thermo Fisher Scientific Inc TMO | Healthcare | 2.89% |
| Amgen Inc AMGN | Healthcare | 2.86% |
Holdings with an ATLAS page link to their probability range, fair value and earnings calendar.
IXJ sector breakdown
| Sector | Weight |
|---|---|
| Healthcare | 100.0% |
By region: North America 75.7%, Europe Developed 14.3%, United Kingdom 5.0%, Japan 3.8%, Australasia 1.0%.
IXJ returns and risk
| Year to date | +6.8% |
|---|---|
| 1 year | +13.8% |
| 3 years (annualised) | +9.0% |
| 5 years (annualised) | +5.5% |
| 10 years (annualised) | +9.4% |
| Volatility (3 years) | 12.9% |
| Sharpe ratio (3 years) | 0.37 |
Past returns do not guarantee future results.
IXJ: frequently asked questions
What does IXJ invest in?
iShares Global Healthcare ETF invests in a portfolio of securities. Its largest holdings are Eli Lilly and Company (10.4%), Johnson & Johnson (7.2%), AbbVie Inc (5.3%), Merck & Company Inc (4.5%), UnitedHealth Group Incorporated (4.1%).
What is the IXJ expense ratio?
0.42% a year: about $42.00 for every $10,000 invested.
What is the IXJ dividend yield?
1.42%. ATLAS does not hold the exact distribution dates for ETFs.
Will IXJ go up?
Nobody can know. The ATLAS model puts the chance of a higher price in one month at 54%, with a likely range (50%) of $109.86 to $116.60 from $112.66 today. It is a probability, not a prediction.
How has IXJ performed?
Year to date +6.8%, one year +13.8%, three years +9.0% a year, five years +5.5% a year. Past returns do not guarantee future results.
Similar ETFs: Healthcare
- State Street Health Care Select Sector SPDR ETF (XLV)
- Vanguard Health Care ETF (VHT)
- iShares U.S. Healthcare ETF (IYH)
- iShares U.S. Medical Devices ETF (IHI)
- Fidelity MSCI Health Care Index ETF (FHLC)
- iShares U.S. Pharmaceuticals ETF (IHE)
- First Trust Health Care AlphaDEX Fund (FXH)
- First Trust Nasdaq Pharmaceuticals ETF (FTXH)
Educational information, not investment advice. Disclaimer